3RJM: Caspase2 In Complex With Chdi Ligand 33c
reference: Exploiting differences in caspase-2 and -3 S(2) subsites for selectivity: Structure-based design, solid-phase synthesis and in vitro activity of novel substrate-based caspase-2 inhibitors., Maillard MC, Brookfield FA, Courtney SM, Eustache FM, Gemkow MJ, Handel RK, Johnson LC, Johnson PD, Kerry MA, Krieger F, Meniconi M, Munoz-Sanjuan I, Palfrey JJ, Park H, Schaertl S, Taylor MG, Weddell D, Dominguez C, Bioorg Med Chem. 2011 Oct 1;19(19):5833-51. Epub 2011 Aug 16. PMID: 21903398

This OCA Structure page
uses Jmol, developed by the Jmol Development Team (documentation).